Cargando…
CD200Fc reduces LPS-induced IL-1β activation in human cervical cancer cells by modulating TLR4-NF-κB and NLRP3 inflammasome pathway
Chronic inflammation plays an important role in tumorigenesis of cervical cancer. CD200Fc, a CD200R1 agonist, has been found to have anti-inflammatory effects in autoimmune diseases and neuro-degeneration. However, the anti-inflammatory effect of CD200Fc on cervical cancer has not yet to be complete...
Autores principales: | He, Aiqin, Shao, Jia, Zhang, Yu, Lu, Hong, Wu, Zhijun, Xu, Yunzhao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464862/ https://www.ncbi.nlm.nih.gov/pubmed/28402258 http://dx.doi.org/10.18632/oncotarget.16596 |
Ejemplares similares
-
Orientin Ameliorates LPS-Induced Inflammatory Responses through the Inhibitory of the NF-κB Pathway and NLRP3 Inflammasome
por: Xiao, Qingfei, et al.
Publicado: (2017) -
Ginsenoside Rb1 Reduces D-GalN/LPS-induced Acute Liver Injury by Regulating TLR4/NF-κB Signaling and NLRP3 Inflammasome
por: Liu, Yimei, et al.
Publicado: (2022) -
CVB3 Inhibits NLRP3 Inflammasome Activation by Suppressing NF-κB Pathway and ROS Production in LPS-Induced Macrophages
por: Wang, Yanqi, et al.
Publicado: (2023) -
MicroRNA-223 attenuates LPS-induced inflammation in an acute lung injury model via the NLRP3 inflammasome and TLR4/NF-κB signaling pathway via RHOB
por: Yan, Yurong, et al.
Publicado: (2019) -
Knockdown of LRRK2 inhibits the progression of lung cancer by regulating TLR4/NF-κB pathways and NLRP3 inflammasome
por: Wu, Junfang, et al.
Publicado: (2023)